HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 283, Issue 30, 21084-21092, July 25, 2008

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 283/30/21084    most recent M710419200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Damian, M. Articles by Banères, J.-L. Search for Related Content PubMed PubMed Citation Articles by Damian, M. Articles by Banères, J.-L. Social Bookmarking                      What's this?

G Protein Activation by the Leukotriene B₄ Receptor Dimer

EVIDENCE FOR AN ABSENCE OF TRANS-ACTIVATION^*

Marjorie Damian, Sophie Mary, Aimée Martin, Jean-Philippe Pin^¶, and Jean-Louis Banères¹

From the Institut des Biomolécules Max Mousseron, CNRS UMR5247, and Institut de Génomique Fonctionnelle, CNRS UMR5203, Universités Montpellier 1 et 2, Montpellier, F-34093 France and ^¶INSERM U661, Montpellier F-34094, France

There is compelling evidence that G protein-coupled receptors exist as homo- and heterodimers, but the way these assemblies function at the molecular level remains unclear. We used here the purified leukotriene B₄ receptor BLT1 stabilized in its dimeric state to analyze how a receptor dimer activates G proteins. For this, we produced heterodimers between the wild-type BLT1 and a BLT1/ALXR chimera. The latter is no longer activated by leukotriene B₄ but is still activated by ALXR agonists. In this heterodimer, agonist binding to either one of the two protomers induced asymmetric conformational changes within the receptor dimer. Of importance, no G protein activation was observed when using a dimer where the ligand-loaded protomer was not able to trigger GDP/GTP exchange due to specific mutations in its third intracellular loop, establishing that the conformation of the agonist-free protomer is not competent for G protein activation. Taken together, these data indicate that although ligand binding to one protomer in the heterodimer is associated with cross-conformational changes, a trans-activation mechanism where the ligand-free subunit would trigger GDP/GTP exchange cannot be considered in this case for G protein activation. This observation sheds light into the way GPCR dimers, in particular heterodimers, could activate their cognate G proteins.

Received for publication, December 21, 2007 , and in revised form, April 30, 2008.

^* This work was supported by CNRS and by French Ministry of Research Grants ACI BCMS 328 and ANR BLAN06-3_135092. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

¹ To whom correspondence should be addressed: Institut des Biomolécules Max Mousseron, Faculté de Pharmacie, 15 Av. Ch. Flahault, BP 14491, 34093 Montpellier Cedex 5, France. Tel.: 33-467-548-668; Fax: 33-467-548-625; E-mail: jean-louis.baneres{at}univ-montp1.fr.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling Blood, June 11, 2009; 113(24): 6085 - 6093. [Abstract] [Full Text] [PDF]

				R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161. [Abstract] [Full Text] [PDF]

				M.-J. Rabiet, E. Huet, and F. Boulay Complement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation J. Biol. Chem., November 7, 2008; 283(45): 31038 - 31046. [Abstract] [Full Text] [PDF]